Literature DB >> 7760058

Glial-neuronal interactions as studied by cerebral metabolism of [2-13C]acetate and [1-13C]glucose: an ex vivo 13C NMR spectroscopic study.

B Hassel1, U Sonnewald, F Fonnum.   

Abstract

Mice were injected intravenously with [2-13C]-acetate or [1-13C]glucose and killed after 5, 15, or 30 min. Another group of animals was injected three times subcutaneously during 30 min with [2-13C]acetate to achieve a steady-state-like situation. Brain extracts were analyzed by 13C NMR spectroscopy, and the percent enrichment of various carbon positions was calculated for amino acids, lactate, and glucose. Results obtained with [2-13C]acetate, which is metabolized by glia and not by neurons, showed that glutamine originated from a glial tricarboxylic acid cycle (TCA cycle) that loses 65% of its intermediates per turn of the cycle. This TCA cycle was associated with pyruvate carboxylation, which may replenish virtually all of this loss, as seen from the labeling of glutamine from [1-13C]glucose. From the C-3/C-4 labeling ratios in glutamine and glutamate and from the corresponding C-3/C-2 labeling ratio in GABA obtained with [2-13C]acetate, it was concluded that the carbon skeleton of glutamine to some extent was passed through TCA cycles before glutamate and GABA were formed. Thus, astrocytically derived glutamine is not only a precursor for transmitter amino acids but is also an energy substrate for neurons in vivo. Furthermore, the neuronal TCA cycles may be control points in the synthesis of transmitter amino acids. Injection of [2-13C]acetate led to a higher 13C enrichment of the C-2 in glutamate and of the corresponding C-4 in GABA than in the C-3 of either compound. This could reflect cleavage of [2-13C]-citrate and formation of [3-13C]oxaloacetate and acetyl-Coa, i.e., the first step in fatty acid synthesis. [3-13C]-Oxaloacetate would, after entry into a TCA cycle, give the observed labeling of glutamate and GABA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760058     DOI: 10.1046/j.1471-4159.1995.64062773.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  40 in total

1.  Targeting glial physiology and glutamate cycling in the treatment of depression.

Authors:  Gerald W Valentine; Gerard Sanacora
Journal:  Biochem Pharmacol       Date:  2009-04-17       Impact factor: 5.858

2.  Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain.

Authors:  Susanna Scafidi; Gary Fiskum; Steven L Lindauer; Penelope Bamford; Da Shi; Irene Hopkins; Mary C McKenna
Journal:  J Neurochem       Date:  2010-05-13       Impact factor: 5.372

Review 3.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

4.  Contribution of extracellular glutamine as an anaplerotic substrate to neuronal metabolism: a re-evaluation by multinuclear NMR spectroscopy in primary cultured neurons.

Authors:  Touraj Shokati; Claudia Zwingmann; Dieter Leibfritz
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

Review 5.  Response to 'comment on recent modeling studies of astrocyte-neuron metabolic interactions': much ado about nothing.

Authors:  Silvia Mangia; Mauro DiNuzzo; Federico Giove; Anthony Carruthers; Ian A Simpson; Susan J Vannucci
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-23       Impact factor: 6.200

6.  Brain [U-13 C]glucose metabolism in mice with decreased α-ketoglutarate dehydrogenase complex activity.

Authors:  Linn Hege Nilsen; Qingli Shi; Gary E Gibson; Ursula Sonnewald
Journal:  J Neurosci Res       Date:  2011-03-03       Impact factor: 4.164

7.  Deletion of Neuronal GLT-1 in Mice Reveals Its Role in Synaptic Glutamate Homeostasis and Mitochondrial Function.

Authors:  Laura F McNair; Jens V Andersen; Blanca I Aldana; Michaela C Hohnholt; Jakob D Nissen; Yan Sun; Kathryn D Fischer; Ursula Sonnewald; Nils Nyberg; Sophie C Webster; Kush Kapur; Theresa S Rimmele; Ilaria Barone; Hannah Hawks-Mayer; Jonathan O Lipton; Nathaniel W Hodgson; Takao K Hensch; Chiye J Aoki; Paul A Rosenberg; Helle S Waagepetersen
Journal:  J Neurosci       Date:  2019-03-29       Impact factor: 6.167

8.  Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy.

Authors:  Silje Alvestad; Janniche Hammer; Elvar Eyjolfsson; Hong Qu; Ole Petter Ottersen; Ursula Sonnewald
Journal:  Neurochem Res       Date:  2007-08-21       Impact factor: 3.996

9.  Measurements of the anaplerotic rate in the human cerebral cortex using 13C magnetic resonance spectroscopy and [1-13C] and [2-13C] glucose.

Authors:  Graeme F Mason; Kitt Falk Petersen; Robin A de Graaf; Gerald I Shulman; Douglas L Rothman
Journal:  J Neurochem       Date:  2006-10-31       Impact factor: 5.372

10.  Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice.

Authors:  Olav B Smeland; Mussie G Hadera; Tanya S McDonald; Ursula Sonnewald; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.